NIHR Biomedical Research Centre

The Royal Marsden, together with its academic partner, The Institute of Cancer Research, London (ICR), is designated as the UK's only National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) dedicated solely to cancer.

The Royal Marsden, together with its academic partner, The Institute of Cancer Research (ICR), is designated as the UK's only National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) dedicated solely to cancer.

NIHR funding

The BRC’s last award was made in 2022 by the NIHR. The funding was for five years and shared among eight research themes. The research themes are:

  • Early Diagnosis, Detection and Stratified Prevention
  • Precision Diagnostics and Cancer Evolution
  • Advanced Technologies for Cure
  • Early Phase Drug Development
  • Precision Therapeutics
  • Immunotherapeutics
  • Cancer Treatment Effects
  • Imaging and Data Science

These eight themes bring together a critical mass of internationally renowned clinicians, scientists and allied health professionals, allowing us to improve outcomes for everyone at risk of and affected by cancer through development of new approaches to preventing cancer, more accurate and earlier diagnosis, and bespoke cancer treatments, underpinned by smart use of data and technology.

You can find out more on the BRC website.